Figure 4From: Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significanceChanges in serum levels of BAFF and APRIL in patients with IgG4-RD during GC therapy. Serum levels of BAFF (a) and APRIL (b) were monitored during and after GC therapy (n = 6).Back to article page